Molecular Therapy-Nucleic Acids
期刊信息导读
- Molecular Therapy-Nucleic Acids基本信息
- Molecular Therapy-Nucleic Acids中科院SCI期刊分区
- 历年Molecular Therapy-Nucleic Acids影响因子趋势图
- Molecular Therapy-Nucleic Acids期刊英文简介
- Molecular Therapy-Nucleic Acids期刊中文简介
Molecular Therapy-Nucleic Acids基本信息
简称:MOL THER-NUCL ACIDS
SCI类别:SCIE
是否OA开放访问:Yes
出版地:UNITED STATES
涉及的研究方向:医学-医学:研究与实验
官方网站:http://www.nature.com/mtna/index.html
投稿网址:http://mts-mtna.nature.com/cgi-bin/main.plex
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-2531%5BISSN%5D
Molecular Therapy-Nucleic Acids期刊英文简介
Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048.
Molecular Therapy-Nucleic Acids期刊中文简介
分子疗法-核酸是一种国际性的、开放获取的期刊,在核酸疗法治疗和/或纠正遗传和获得性疾病的广泛领域中,出版高质量的基础、翻译和临床研究。研究领域包括但不限于:基于核酸及其衍生物的治疗方法的开发、基于rna的治疗方法的载体开发和设计、基因修饰剂的应用,包括形成三聚体的寡核苷酸和酶(如锌指核酸酶)、临床前目标验证、安全性/有效性研究和临床试验。分子治疗-核酸2015影响因子为5.048。
中科院SCI期刊分区:
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 2区 | 否 | 否 |
Molecular Therapy-Nucleic Acids影响因子